Previous close | 74.92 |
Open | 74.93 |
Bid | 75.07 x 500 |
Ask | 75.13 x 500 |
Day's range | 74.53 - 75.24 |
52-week range | 64.02 - 87.88 |
Volume | |
Avg. volume | 1,790,124 |
Market cap | 17.628B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 35.59 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.